Creative Biolabs-Immuno-oncology

Anti-CD83 (clone 39QA2E) SynExpress C-Cy5-β-B Modified CD8+ T cells (CAT#: ITS-1224-CR1872)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD83 (clone 39QA2E). We employs the pCDNA (CMV-Cy5-β-catenin-BamHI) vector components and the SynExpress system of the Exons Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD83
Clone
39QA2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
β-catenin
Insertion Sites
BamHI
Gene Modification
Base Editing
Modification Domain
Exons
Carrier Type
pCDNA
Transformation Accuracy
0.94
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.